Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Nolta

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Blood|October 24, 2002
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitutionMo A Dao, Jesusa Arevalo, Jan A Nolta
Current Opinion in Hematology|November 19, 2004
Recent advances in hematopoietic stem cell biologyJesper Bonde, David A Hess, Jan A Nolta
Blood|January 10, 2002
Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitorsMo A Dao, Joseph Hwa, Jan A Nolta
Stem Cells (Dayton, Ohio)|April 9, 2017
Concise Review: Stem Cells in OsteoimmunologyFernando A Fierro, Jan A Nolta, Iannis E Adamopoulos
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 20, 2009
Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoyJoseph S Anderson, John Javien, Jan A Nolta, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2009
Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunizationJoseph S Anderson, Jon Walker, Jan A Nolta, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapyFernando A Fierro, Stefanos Kalomoiris, Claus S Sondergaard, et al.
Stem Cells (Dayton, Ohio)|May 27, 2014
Concise review: MicroRNA function in multipotent mesenchymal stromal cellsElizabeth A Clark, Stefanos Kalomoiris, Jan A Nolta, et al.
Stem Cells Translational Medicine|May 31, 2022
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC ProductsGuido Moll, James A Ankrum, Scott D Olson, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Blood|October 24, 2002
Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitutionMo A Dao, Jesusa Arevalo, Jan A Nolta
Current Opinion in Hematology|November 19, 2004
Recent advances in hematopoietic stem cell biologyJesper Bonde, David A Hess, Jan A Nolta
Blood|January 10, 2002
Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitorsMo A Dao, Joseph Hwa, Jan A Nolta
Stem Cells (Dayton, Ohio)|April 9, 2017
Concise Review: Stem Cells in OsteoimmunologyFernando A Fierro, Jan A Nolta, Iannis E Adamopoulos
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 20, 2009
Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoyJoseph S Anderson, John Javien, Jan A Nolta, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2009
Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunizationJoseph S Anderson, Jon Walker, Jan A Nolta, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapyFernando A Fierro, Stefanos Kalomoiris, Claus S Sondergaard, et al.
Stem Cells (Dayton, Ohio)|May 27, 2014
Concise review: MicroRNA function in multipotent mesenchymal stromal cellsElizabeth A Clark, Stefanos Kalomoiris, Jan A Nolta, et al.
Stem Cells Translational Medicine|May 31, 2022
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC ProductsGuido Moll, James A Ankrum, Scott D Olson, et al.
Pageof 13